MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

CUSIP: 62855J104

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93,057,750
Total 13F shares
92,186,830
Share change
+4,676,306
Total reported value
$567,096,921
Put/Call ratio
0%
Price per share
$6.15
Number of holders
218
Value change
+$27,523,507
Number of buys
111
Number of sells
98

Quarterly Holders Quick Answers

What is CUSIP 62855J104?
CUSIP 62855J104 identifies MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2025

As of 31 Dec 2025, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by 218 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,186,830 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., MORGAN STANLEY, JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 218 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.